The check engine light is the worst kind of message. It tells you something is wrong without telling you what, and the dealership will happily charge a ...

On the first day of the new automated ball-strike (ABS) challenge system, the Mariners didn’t initiate any challenges Thursday night. Cleveland challenged two calls, winning one and losing one. Each ...

The 2026 MLB season is officially here, but not without one of the most major changes in the history of the sport. After a century-and-a-half of complete human element behind home plate, batters, ...

Apple will spend $400 million through 2030 on new programs with Bosch, Cirrus Logic, TDK, and Qnity Electronics to manufacture essential materials and components in the U.S. The expansion builds on ...

With a new Major League Baseball season here, a major change will play a unique role in how the year progresses. Coming to the majors this season is the Automated Ball-Strike Challenge System, or ABS ...

After tinkering with the Automated Ball-Strike (ABS) challenge system for a few years, MLB brought the technology to the regular season in 2026. It didn’t take long before the new technology was put ...

The era of the Automated Ball-Strike Challenge System has begun, and the New York Mets were the first team in major league history to benefit from it. During the Mets' season-opener against the ...

SAN FRANCISCO — There it was, for the first time in Major League Baseball history, the outcome of a ball-strike call deciding by a machine. It happened in the fourth inning Wednesday night in the New ...

Major League Baseball has made some serious changes to the sport in recent years. From the universal DH to replay challenges to pitch clocks, and 2026 will be no different. This year, the league is ...

Baseball season is officially here and the biggest talking point ahead of the new year has been the implementation of the Automated-Ball Strike system. Tested last year during spring training then ...

VANCOUVER, Wash. and NEW YORK - Absci Corporation (NASDAQ:ABSI) announced today the formation of an advisory board for its ABS-201 program, a therapeutic antibody treatment in clinical development for ...